Composition

Each 1 ml contains:

• Flunixin meglumine 50 mg

Pharmaceutical Form

Sterile injectable solution

Pharmacological Properties

Flunixin is a non-steroidal anti-inflammatory drug (NSAID) with potent non-narcotic analgesic and antipyretic properties. Flunixin meglumine works by inhibiting cyclooxygenase, an enzyme involved in the formation of prostaglandins that mediate inflammation, pain, and fever. It is widely used for managing musculoskeletal pain and inflammation in horses, and for controlling acute inflammation associated with infectious diseases in cattle.

Target Species

Horses and cattle

Indications for Use

Horses
Sedaflux Injection is indicated for the relief of inflammation and pain associated with musculoskeletal disorders, and for the management of visceral pain due to colic. It is also useful in conditions involving endotoxemia or septic shock, such as gastric torsion, where blood circulation to the gastrointestinal tract is compromised.

Cattle
Indicated for the control of acute inflammation related to respiratory infections. It is also recommended as adjunctive therapy in cases of acute mastitis.

Contraindications

Avoid intra-arterial administration in both horses and cattle. Accidental intra-arterial injection in horses may cause adverse reactions such as ataxia, incoordination, hyperventilation, excitement, or muscle weakness. These signs are transient and typically resolve without the need for specific treatment.

Undesirable Effects

No undesirable effects have been observed when used as directed.

Posology and Method of Administration

Sedaflux Injection can be administered by intravenous (IV) or intramuscular (IM) injection.

• Horses: 1.1 mg flunixin/kg body weight, equivalent to 1 ml per 45 kg, once daily via IV or IM route, for up to 5 consecutive days.
• Cattle: 2.2 mg flunixin/kg body weight, equivalent to 2 ml per 45 kg, once daily via IV or IM route, for up to 3 consecutive days.

Overdose

No adverse effects have been reported with overdose under normal usage.

Withdrawal Period

• Cattle (meat): 7 days after the last treatment
• Cattle (milk): Milk from treated cows is safe for human consumption

Special Safety Precautions for the Person Administering the Product

Intra-arterial injection should be strictly avoided in horses and cattle.

Special Precautions for Storage

Store below 30°C.
Do not refrigerate.
Protect from light.

Packaging

Available in 50 ml and 100 ml amber glass vials.

For veterinary use only. Consult a veterinarian before use.